Pfizer and its German partner BioNTech asked London's Court of Appeal on Thursday to overturn a ruling that their COVID-19 ...

China’s Clover Biopharmaceuticals Ltd. (02197.HK) was finally looking to the future after a big bet on Covid vaccines failed to pay off. However, decisions made early on in the pandemic are still ...

A legal battle between rival developers of Covid-19 jabs over vaccine technology patents has produced a mixed ruling from a High Court judge.

While money from Covid vaccine sales is a key driver of the dispute, the patent battle could prove influential for the development of future mRNA-based products.

Pfizer (PFE) and BioNTech (BNTX) challenge Moderna's patent win in London court over mRNA COVID-19 vaccine technology. Read ...

As COVID vaccine patent dispute drags on, Moderna forks over $400M to NIH Moderna called the sum a "catch-up payment" for borrowing a molecular technique.

Moderna has won a case at the European Patent Office in its dispute with Pfizer and BioNTech over its Covid-19 vaccine, in a boon for the mRNA-vaccine maker in its ongoing legal fight to recoup ...

Pfizer Inc PFE, BioNTech SE BNTX, and Moderna Inc MRNA were named in lawsuits by Promosome accusing their COVID-19 vaccines of infringing a patent related to messenger RNA (mRNA) technology. The ...

Covid-19 vaccine patent legal battle heading to Court of Appeal Moderna, Pfizer and BioNTech are locked in dispute over the rights to vaccine technology patents.

The companies behind two of America’s most widely used covid-19 vaccines are at loggerheads. Despite promising publicly not to enforce covid-19-related patents until the pandemic was over ...

European Patent Office Sides with Moderna In COVID-19 Vaccine Patent Dispute With Pfizer/BioNTech Vandana Singh Fri, May 17, 2024, 2:46 PM2 min read ...